Related Experiment Videos
Rapid conversion from one monoamine oxidase inhibitor to another
M P Szuba1, M Hornig-Rohan, J D Amsterdam
1Depression Research Unit, University of Pennsylvania Health System, Philadelphia, USA.
The Journal of Clinical Psychiatry
|July 1, 1997
Summary
Rapidly switching monoamine oxidase (MAO) inhibitors is feasible in some patients, reducing the need for lengthy drug-free periods. This approach requires careful monitoring and is suitable for compliant patients needing swift treatment changes.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Standard practice dictates a 14-day washout period when switching between monoamine oxidase (MAO) inhibitors.
- This extended period is often impractical for hospitalized or severely depressed patients.
Purpose of the Study:
- To investigate the safety and efficacy of rapid MAO inhibitor conversion in select patient populations.
- To determine if shorter or no washout periods are viable alternatives.
Main Methods:
- A retrospective review of eight consecutive patients undergoing MAO inhibitor conversion with less than the standard washout period.
- Case histories were analyzed for adverse effects and treatment response.
Main Results:
- One patient experienced transient, mild adverse effects possibly related to withdrawal or mild serotonin syndrome.
- The remaining seven patients tolerated the switch with minimal to no adverse effects.
- Four of the eight patients demonstrated a positive response to the new MAO inhibitor.
Conclusions:
- Rapid MAO inhibitor switching may be a safe and effective strategy for carefully selected patients.
- This approach necessitates close patient monitoring, high compliance, and adherence to a low-tyramine diet.
- Further research is needed to establish the precise risks and benefits of rapid MAO inhibitor conversion.